European Journal of Internal Medicine

Papers
(The H4-Index of European Journal of Internal Medicine is 36. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Electrocardiographic changes associated with hypothermia282
Non-pharmacological home remedies used by primary care patients252
Effects of the implementation of the dynamic silver code in the emergency department195
The role of age in recognizing cognitive impairment in the emergency department169
A man with brown macules on the limbs168
Impact of L-arginine and liposomal vitamin C supplementation on quality of life and daily life activities in patients with COPD: a randomized, multicenter, single blind, placebo-controlled trial (ILDA160
Impact of thoracoabdominal imaging on diagnosis and management in patients with suspected infective endocarditis133
The impact of the COVID-19 Pandemic on hypertension phenotypes (ESH ABPM COVID-19 study)92
Concerns regarding result analysis and the corresponding risk of pulmonary embolism severity and in-hospital mortality90
How the theory of centralized aerobic-anaerobic energy balance compensation explains sudden cardiac death in young athletes85
Heart failure: An autopsy case82
Effects of statins on clinical outcomes in hospitalized patients with COVID-1982
Natural history of ‘silent’ atrial fibrillation from subclinical to asymptomatic: State of the art and need for research81
The peculiarities of COVID-19 in older people: Considerations after two years64
A woman with purple-brown skin lesions after immunosuppressive therapy61
Health differences between adults with and without intellectual disabilities at the internal medicine department: A first step to improve awareness of intellectual disabilities among healthcare profes59
A call to action: The need to apply guidelines recommendations with ABC or SOS to improve stroke prevention and cardiovascular outcomes in patients with atrial fibrillation58
Structural evolution of severe acute respiratory syndrome coronavirus 2: Implications for adhesivity to angiotensin-converting enzyme 2 receptors and vaccines51
Impact of adherence to EULAR quality indicators on the quality of life of patients with systemic lupus erythematosus48
Uncomplicated outpatient deep venous thrombosis management with a novel care pathway: Is it ready for prime time?47
Risk trajectory of cardiovascular events after an exacerbation of chronic obstructive pulmonary disease: A systematic review and meta-analysis46
Reconsidering the Edelman equation: impact of plasma sodium concentration, edema and body weight46
Trial sequential analysis methodology for interpreting meta-analytical findings46
Refining metabolic health assessment in inflammatory bowel disease risk prediction45
Refining risk assessment for intra-abdominal infections in immunocompromised intensive care unit patients45
Prevalence of post-COVID symptoms one-year after SARS-CoV-2 infection in patients with interstitial lung disease43
Association between interleukin-6, C-reactive protein and chronic kidney disease outcomes: A systematic review and meta-analysis42
A hidden cause of sudden epigastric pain in a middle-aged man42
Recurrent vomiting41
Prognostic impact of hypertension grading40
Telemedicine in internal medicine: A statement by the European Federation of Internal Medicine.40
Comparative analysis of obesity indices in discrimination and reclassification of cardiovascular disease risk: The ATTICA study (2002–2022)40
Sodium-glucose cotransporter2 inhibitor-associated ketoacidosis in nondiabetic patients40
Efficacy and safety assessment of mineralocorticoid receptor antagonists in patients with chronic kidney disease39
Endothelin-1 as dual marker for renal function decline and associated cardiovascular complications in patients with chronic kidney disease37
Aspirin and P2Y12 inhibitors in treating COVID-1937
To dilate or not to dilate: the puzzle of phenotyping heart failure with mildly reduced ejection fraction36
0.15026712417603